Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;42(4):123-126.
doi: 10.18773/austprescr.2019.039. Epub 2019 Aug 1.

Venous thromboembolism: current management

Hannah Stevens  1   2 , Huyen Tran  1   2 , Harry Gibbs  1   2
Affiliations
Review

Venous thromboembolism: current management

Hannah Stevens et al. Aust Prescr. 2019 Aug.

Abstract

Anticoagulation is indicated in most cases of venous thromboembolism

Monotherapy with rivaroxaban or apixaban is the preferred option for most adults with acute venous thromboembolism

There are no recommended dose reductions for rivaroxaban or apixaban in venous thromboembolism, unlike for atrial fibrillation

The initial duration of anticoagulation is usually three months

Extended treatment with low-dose rivaroxaban or apixaban is effective in preventing recurrence in patients with a continuing increased risk of thromboembolism. Both drugs have low rates of major bleeding

Keywords: anticoagulants; apixaban; rivaroxaban; venous thromboembolism; warfarin.

PubMed Disclaimer

Figures

Fig
Fig
Initial treatment of venous thromboembolism
See this image and copyright information in PMC

References

    1. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol 2015;12:464-74. 10.1038/nrcardio.2015.83 - DOI - PMC - PubMed
    1. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960;1:1309-12. 10.1016/S0140-6736(60)92299-6 - DOI - PubMed
    1. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010;363:266-74. 10.1056/NEJMra0907731 - DOI - PubMed
    1. Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, et al. EINSTEIN Investigators Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010;363:2499-510. 10.1056/NEJMoa1007903 - DOI - PubMed
    1. Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, et al. EINSTEIN–PE Investigators Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012;366:1287-97. 10.1056/NEJMoa1113572 - DOI - PubMed

LinkOut - more resources